エイズおよび抗HIV薬開発研究について
スポンサーリンク
概要
- 論文の詳細を見る
The unprecedented speed with which the etiologic agent of AIDS, human immunodeficiency virus (HIV) , was isolated and characterized, and then effective drugs were discovered remarkably. Discovery of some anti-HIV compounds suggested that the antiviral chemotherapy of AIDS was fesible, and opened the search for more potent and more selective anti-HIV agents. In the past two years, HIV-infected patients have been treated with combinations of drugs which inhibit enzymes present in HIV but not in human. Most have thereupon become able to forestall or even overcome opportunistic infections, and have exhibited decresed quantities of viral load and increased numbers of CD4 Iymphocytes. In addition, HIV coreceptors, CXCR4 and CCR5,were identified and their important roles for virus entry would be disclosuring. This review will focus on the latest basic research of AIDS and anti-HIV drug development.
- 鹿児島大学の論文
- 1998-03-25
著者
関連論文
- エイズ治療薬開発の現状
- 新しいウイルス治療薬の展望 (特集 ウイルス感染症対策)
- Abiotrophia属のマイトジェン刺激リンパ球に対する増殖抑制能
- HIV感染のコレセプター,CXCR4,を標的とした抗HIV薬の開発
- 緑色レンサ球菌臨床分離株におけるスーパー抗原性外毒素産生の検索
- エイズおよび抗HIV薬開発研究について
- 植物抽出物の抗ウイルスおよび抗酸化作用に関する研究
- HIV-1:エントリーインヒビターとスキン免疫
- Comparisons of Site-specific Reactions to Administered Infections in Rats